Quantifying Synergy for Combination Drug Studies
*John Joseph Peterson, GlaxoSmithKline Pharmaceuticals Keywords: Combination drug therapies offer much promise for treating cancer, infectious diseases, and other diseases involving multiple cellular pathways. However, until now a truly general approach to quantifying “drug synergy” has not been available in the biomedical literature. This roundtable will provide a brief overview of classical measures of drug synergy and their drawbacks, and also discuss a new quantitative approach based upon mixture experiments.
|
Key Dates
-
April 30 - May 22, 2013
Invited Abstract Submission Open -
June 4, 2013
Online Registration Opens -
August 9 - August 23, 2013
Invited Abstract Editing -
August 23, 2013
Short Course materials due from Instructors -
August 26, 2013
Housing Deadline -
September 9, 2013
Cancellation Deadline and Registration Closes @ 11:59 pm EDT -
September 16 - September 18, 2013
Marriott Wardman Park, Washington, DC